-
2023-505379-61-00
4
2024-01-17
Acute Myeloid Leukaemia
-
2022-501515-14-00
5
2023-09-29
Newly Diagnosed Multiple Myeloma (NDMM)
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2023-508389-13-00
5
2022-11-08
Combined endpoint of all-cause mortality, kidney failure, and hospital
-
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2023-505449-18-00
4
2020-07-23
Patients with relapsed CLL
-
2024-518457-42-00
4
2025-08-28
chronic kidney disease
-
2024-518998-33-00
5
2025-07-23
Ulcerative Colitis
-
2024-517143-31-00
4
2025-07-18
Autosomal Dominant Polycystic Kidney Disease
-
2024-516511-24-00
11
2024-11-14
Chronic myeloid leukaemia
-
2024-511530-12-01
6
2024-10-01
Rheumatoid arthritis according to 2010 criteria
-
2022-502808-72-00
4
2024-09-11
Chronic Lymphocytic Leukemia
-
2024-510965-41-00
5
2024-09-03
Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
-
2024-516379-34-00
6
2024-08-02
Myopia
-
2022-502781-24-01
5
2024-06-05
ASCVD - Atherosclerotic Cardiovascular Disease
-
2023-506457-38-00
5
2024-06-05
Chronic kidney disease (CKD) and hypertension.
-
2023-508630-34-00
5
2024-05-28
Overweight
-
2023-506948-17-00
5
2024-04-05
Previously Untreated Chronic Lymphocytic Leukemia
-
2023-504124-26-00
5
2024-04-04
Chronic Kidney Disease and High Proteinuria
-
2022-501396-62-00
5
2023-12-12
Relapsed Refractory Multiple Myeloma
-
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer